YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (HK:1558) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. is progressing with its planned privatization through a merger with Sunshine Lake Pharma Co., Ltd., having fulfilled one of its pre-conditions recently. The company is also preparing for the listing of its H shares on the Hong Kong Stock Exchange, with relevant approvals still pending. Investors are advised to stay tuned for further updates on this significant corporate restructuring.
For further insights into HK:1558 stock, check out TipRanks’ Stock Analysis page.

